AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
North America Commercial Headquarters
1800 Concord Pike
P.O. Box 15437
Wilmington, DE 19850
+1 (302) 886-3000
RELATED ARTICLES
Researcher Profile: René van der Merwe
Biologics could bring an end to today’s “one size fits all” approach to treating asthma says René va…
READ MORE
Innovation gave me back my ability to breathe
Gil shares his experience living with severe asthma, and the impact new treatments have on his life.
READ MORE
Researcher Profile: Roland Kolbeck
Dr. Kolbeck led a team of researchers to develop what has become AstraZeneca’s first respiratory bio…
READ MORE
A New Era for Asthma Treatment
With more than 100 medicines for respiratory diseases currently in development and 49 medicines for…
READ MORE
Researcher Profile: David Cobden
Learn about what America's biopharmaceutical companies are doing to ensure we can continue to afford…
READ MORE
Improving Cancer Treatment by Studying DNA Damage Response
DNA damage response (DDR) is a term used to describe the network of cellular pathways that minimize…
READ MORE
Searching for a Cure for Heart Failure
Researchers at AstraZeneca have focused extensive research and resources on developing a treatment t…
READ MOREPOPULAR ARTICLES
Can We Afford the New Era of Medicine?
Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.
READ MORE
Researcher Profile: Jirong Lu
Dr. Jirong Lu, a distinguished research fellow at Eli Lilly and Company (Lilly), traces the beginnings of her career to a high school fascination with chemistry.
READ MORE
Policy Solutions to Push Progress Forward
We are in a new era of medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we must not take this progress for granted.
READ MORE
The Greatest Gift of All: Hope
My son Parker's journey with juvenile arthritis (JA) began 10 years ago when he was in elementary school.
READ MORE
Migraine: More than Just a Bad Headache
Migraine is a debilitating neurological disease that is often misunderstood by those who do not suffer symptoms, according to the Migraine Impact Report, a new survey recently released by Eli Lilly and Company and conducted by Nielsen.
READ MORE
Washington is considering policy changes that could threaten innovation
New policy proposals in Washington threaten to hamstring investment in innovation and jeopardize breakthroughs.
READ MORE
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
READ MORE